Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Alcohol Drinking 6Pancreatic Neoplasms 5Neoplasms 3Smoking Cessation 2Smoking 2Pancreatic Cyst 2Multiple Endocrine Neoplasia Type 1 2Head and Neck Neoplasms 2Depression 2Alcoholism 2Warts 1Urinary Bladder Neoplasms 1Torulopsis 1Tobacco Use Disorder 1Thyroid Nodule 1Substance-Related Disorders 1Social Isolation 1Sexual Behavior 1Postoperative Complications 1Papillomavirus Infections 1Pancreatitis, Chronic 1Pancreatic Intraductal Neoplasms 1Pain 1Neuroblastoma 1Neoplasms, Cystic, Mucinous, and Serous 1Lymphoma 1Lung Neoplasms 1Leukoplakia, Oral 1Leukemia 1Homosexuality 1

Interventions

Gemcitabine 35Cisplatin 21Capecitabine 17Oxaliplatin 16Leucovorin 11Fluorouracil 11pembrolizumab 8S 1 (combination) 8Nivolumab 6tremelimumab 5durvalumab 5Bevacizumab 5lenvatinib 4Irinotecan 4trametinib 3titanium silicide 3atezolizumab 3Radiofrequency Ablation 3zanidatamab 2vandetanib 2irinotecan sucrosofate 2derazantinib 2camrelizumab 2binimetinib 2apatinib 2Trastuzumab 2Tegafur 2Radiotherapy 2Panitumumab 2Ipilimumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Biliary Tract Neoplasms × Ethanol × Clear all
NCT02002806 2019-08-16

Surgery Plus Celiac Nerve Block for Long-term Pancreatic Cancer Pain Control

Indiana University

Phase NA Completed
150 enrolled
Gastrointestinal

Biliary Tract Neoplasms, Pain, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡